Apr
18
by
CEA Registry Team
4/18/2017 1:08 PM
This week we highlighted findings from recently published cost-effectiveness studies:
- Offering patients a choice of influenza vaccine type decreases disease burden at a reasonable cost: Simulating a population of a large metropolitan area, a new study found that offering a choice of influenza vaccine type significantly reduced the number of influenza cases with favorable cost-effectiveness. (6)
- Majority of literature on spinal cord stimulation for chronic back and limb pain demonstrates favorable cost-effectiveness: Review of the literature on spinal cord stimulation demonstrates an advantageous cost-effectiveness profile for treating chronic neuropathic pain when compared to reoperation and medical management. (10)
- Progress in producing evidence to inform economic decision models in Health Technology Assessments of diagnostic tests: Appropriate meta-analysis methods in synthesizing evidence on diagnostic test accuracy for informing cost-effectiveness analyses have improved in recent years in the UK. (16)
See below for a full list of all cost-utility studies and selected reviews and editorials published April 10-14, 2017. To discover more CEA articles or to dive in-depth on some of these topics, please visit the Tufts CEA Registry. Follow us on Twitter (@TuftsCEVR) and Facebook.
1: Algattas H, et al. Systematic Review of Safety and Cost-Effectiveness of Venous Thromboembolism Prophylaxis Strategies in Patients Undergoing Craniotomy for Brain Tumor. Neurosurgery. 2017 Apr 11. PMID: 28402497.
2: Anderson D, Lehmann J, Ecker T, Vosgerau S, Donatz V. [Cost effectiveness of
GnRH antagonists in patients with prostate cancer and cardiovascular risk: Comparative analysis against Leuprorelin by the Number Needed to Treat]. Urologe A. 2017 Apr 12. PMID: 28405705.
3: Carvalho AC, Leal F, Sasse AD. Cost-effectiveness of cetuximab and panitumumab
for chemotherapy-refractory metastatic colorectal cancer. PLoS One. 2017 Apr 12;12(4):e0175409. PMID: 28403233.
4: Clark LA, Whitmire S, Patton S, Clark C, Blanchette CM, Howden R. Cost-effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers as first-line treatment in autosomal dominant polycystic kidney disease. J Med Econ. 2017 Apr 13:1-8. PMID: 28332417.
5: de Lorenzo-Pinto A, Herranz-Alonso A, Cuéllar-Basterrechea B, Bellón-Cano JM,
Sanjurjo-Sáez M, Bueno H. Clinical and Economic Impact of a Multisciplinary Intervention to Reduce Bleeding Risk in Patients With Acute Coronary Syndrome.Rev Esp Cardiol (Engl Ed). 2017 Apr 11. PMID:28411029.
6: DePasse JV, Smith KJ, Raviotta JM, Shim E, Nowalk MP, Zimmerman RK, Brown ST.
Does Choice of Influenza Vaccine Type Change Disease Burden and Cost-Effectiveness in the United States? An Agent-Based Modeling Study. Am J Epidemiol. 2017 Apr 10:1-10. PMID: 28402385.
7: Favato G, Easton T, Vecchiato R, Noikokyris E. Ecological validity of cost-effectiveness models of universal HPV vaccination: A systematic literature review. Vaccine. 2017 Apr 10. pii: S0264-410X(17)30445-0. PMID: 28408119.
8: Gee Kee E, Stockton K, Kimble RM, Cuttle L, McPhail SM. Cost-effectiveness of silver dressings for paediatric partial thickness burns: An economic evaluation from a randomized controlled trial. Burns. 2017 Apr 10. PMID: 28408145.
9: Greuter MJ, Schouten CS, Castelijns JA, de Graaf P, Comans EF, Hoekstra OS, de Bree R, Coupé VM. Cost-effectiveness of response evaluation after chemoradiation in patients with advanced oropharyngeal cancer using (18)F-FDG-PET-CT and/or diffusion-weighted MRI. BMC Cancer. 2017 Apr 11;17(1):256. PMID: 28399836.
10: Hoelscher C, Riley J, Wu C, Sharan A. Cost-Effectiveness Data Regarding Spinal Cord Stimulation for Low Back Pain. Spine (Phila Pa 1976). 2017 Apr 10.PMID: 28399549.
11: Kerr C. Cost-effectiveness of web-based therapy: what's it worth? Dev Med Child Neurol. 2017 Apr 11. PMID: 28398000.
12: Kohn CG, Zeichner SB, Chen Q, Montero AJ, Goldstein DA, Flowers CR. Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced Melanoma. J Clin Oncol. 2017 Apr 10;35(11):1194-1202. PMID: 28221865.
13: McFerran E, O'Mahony JF, Fallis R, McVicar D, Zauber AG, Kee F. Evaluation of the Effectiveness and Cost-Effectiveness of Personalized Surveillance After Colorectal Adenomatous Polypectomy. Epidemiol Rev. 2017 Apr 10:1-13. PMID: 28402402.
14: Miyazaki S, et al. Quality of life and cost-utility of surgical treatment for patients with spinal
metastases: prospective cohort study. Int Orthop. 2017 Apr 10.PMID: 28396928.
15: Ruiz-Ramos J, et al. Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care units. J Med Econ. 2017 Apr 13:1-8. PMID:28345481.
16: Shinkins B, Yang Y, Abel L, Fanshawe TR. Evidence synthesis to inform model-based cost-effectiveness evaluations of diagnostic tests: a methodological review of health technology assessments. BMC Med Res Methodol. 2017 Apr 14;17(1):56. PMID: 28410588.
17: Tomata Y, Watanabe T, Sugiyama K, Zhang S, Sugawara Y, Tsuji I. Effects of a Community-Based Program for Oral Health and Nutrition on Cost-Effectiveness by Preventing Disability in Japanese Frail Elderly: A Quasi-Experimental Study Using Propensity Score Matching. J Am Med Dir Assoc. 2017 Apr 12. PMID: 28412165.